Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Joan, Gibert"'
Autor:
Max Hardy-Werbin, José Maria Maiques, Marcos Busto, Isabel Cirera, Alfons Aguirre, Nieves Garcia-Gisbert, Flavio Zuccarino, Santiago Carbullanca, Luis Alexander Del Carpio, Didac Ramal, Ángel Gayete, Jordi Martínez-Roldan, Albert Marquez-Colome, Beatriz Bellosillo, Joan Gibert
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract The rapid spread of the severe acute respiratory syndrome coronavirus 2 led to a global overextension of healthcare. Both Chest X-rays (CXR) and blood test have been demonstrated to have predictive value on Coronavirus Disease 2019 (COVID-19
Externí odkaz:
https://doaj.org/article/3ae2a8c98443459290162cd00ba2c0fd
Autor:
Mariagiulia Dal Cero, Joan Gibert, Luis Grande, Marta Gimeno, Javier Osorio, Maria Bencivenga, Uberto Fumagalli Romario, Riccardo Rosati, Paolo Morgagni, Suzanne Gisbertz, Wojciech P. Polkowski, Lucio Lara Santos, Piotr Kołodziejczyk, Wojciech Kielan, Rossella Reddavid, Johanna W. van Sandick, Gian Luca Baiocchi, Ines Gockel, Andrew Davies, Bas P. L. Wijnhoven, Daniel Reim, Paulo Costa, William H. Allum, Guillaume Piessen, John V. Reynolds, Stefan P. Mönig, Paul M. Schneider, Elisenda Garsot, Emma Eizaguirre, Mònica Miró, Sandra Castro, Coro Miranda, Xavier Monzonis-Hernández, Manuel Pera, on behalf of the Spanish EURECCA Esophagogastric Cancer Group and the European GASTRODATA Study Group
Publikováno v:
Cancers, Vol 16, Iss 13, p 2463 (2024)
Background: Radical gastrectomy remains the main treatment for gastric cancer, despite its high mortality. A clinical predictive model of 90-day mortality (90DM) risk after gastric cancer surgery based on the Spanish EURECCA registry database was dev
Externí odkaz:
https://doaj.org/article/512cdc1d1ebd4fa3956cf82f6ec8f73c
Autor:
Sergi Clavé, Jennifer B. Jackson, Marta Salido, Jacob Kames, Kelly M. R. Gerding, Ellen L. Verner, Eric F. Kong, Elizabeth Weingartner, Joan Gibert, Max Hardy-Werbin, Pedro Rocha, Xènia Riera, Erica Torres, James Hernandez, Gustavo Cerqueira, Donna Nichol, John Simmons, Álvaro Taus, Lara Pijuan, Beatriz Bellosillo, Edurne Arriola
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionNext-generation sequencing (NGS) is currently widely used for biomarker studies and molecular profiling to identify concurrent alterations that can lead to the better characterization of a tumor’s molecular landscape. However, further e
Externí odkaz:
https://doaj.org/article/80540fee92c8444d8cf2e823ff47914c
Autor:
Ramón Diez-Feijóo, Marcio Andrade-Campos, Joan Gibert, Blanca Sánchez-González, Lierni Fernández-Ibarrondo, Concepción Fernández-Rodríguez, Nieves Garcia-Gisbert, Laura Camacho, Marta Lafuente, Ivonne Vázquez, Luis Colomo, Antonio Salar, Beatriz Bellosillo
Publikováno v:
Cancers, Vol 16, Iss 2, p 321 (2024)
Background: Cell-free DNA (cfDNA) analysis has become a promising tool for the diagnosis, prognosis, and monitoring of lymphoma cases. Until now, research in this area has mainly focused on aggressive lymphomas, with scanty information from other lym
Externí odkaz:
https://doaj.org/article/b286e24faac54eaf89dcd2c0042d9ffa
Autor:
Juan Jose Rodríguez-Sevilla, Concepción Fernández-Rodríguez, Leyre Bento, Ramón Diez-Feijóo, Sergio Pinzón, Joan Gibert, Lierni Fernández-Ibarrondo, Marta Lafuente, Ana Ferrer, Blanca Sánchez-González, Eva Gimeno, Juan Sainz, Rafael Ramos, Juan F. García, Lluis Colomo, Beatriz Bellosillo, Antonio Gutiérrez, Antonio Salar
Publikováno v:
Blood Advances. 7:1606-1614
Several clinical risk models have been proposed to predict the outcome of follicular lymphoma (FL). The development of next-generation sequencing technologies has allowed the integration of somatic gene mutations into clinical scores to build genotyp
Autor:
Pedro Rocha, MD, Didac Ramal, MD, Enric Ripoll, MD, Laura Moliner, MD, Alex Corbera, MD, Max Hardy-Werbin, MD, PhD, Mayra Orrillo, MD, Álvaro Taus, MD, Flavio Zuccarino, MD, Joan Gibert, Júlia Perera-Bel, David Casadevall, MD, PhD, Edurne Arriola, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 1, Pp 100115- (2021)
Introduction: Hyperprogressive disease (HPD) as a consequence of immune checkpoint inhibitors in NSCLC has been reported in multiple studies. However, inconsistent results in incidence and survival outcomes within studies, together with different ass
Externí odkaz:
https://doaj.org/article/aa5ac2c35017431287482d1faf250d70
Autor:
Nieves Garcia-Gisbert, Leonor Arenillas, David Roman-Bravo, Juan Jose Rodriguez-Sevilla, Concepción Fernández-Rodríguez, Sara Garcia-Avila, Patricia Velez, Joan Gibert, Lierni Fernández-Ibarrondo, Antonio Salar, Lourdes Florensa, Beatriz Bellosillo, Ana Ferrer, Xavier Calvo
Publikováno v:
Leukemia. 36:2922-2926
Autor:
Manuel, Pera, Joan, Gibert, Marta, Gimeno, Elisenda, Garsot, Emma, Eizaguirre, Mónica, Miró, Sandra, Castro, Coro, Miranda, Lorena, Reka, Saioa, Leturio, Marta, González-Duaigües, Clara, Codony, Yanina, Gobbini, Alexis, Luna, Sonia, Fernández-Ananín, Aingeru, Sarriugarte, Carles, Olona, Joaquín, Rodríguez-Santiago, Javier, Osorio, Luis, Grande
Publikováno v:
Annals of Surgery. 276:776-783
Objective: to develop and validate a risk prediction model of 90-day mortality (90DM) using machine learning in a large multicenter cohort of patients undergoing gastric cancer resection with curative intent. Background: the 90DM rate after gastrecto
Autor:
Xavier Calvo, David Roman-Bravo, Nieves Garcia-Gisbert, Juan Jose Rodriguez-Sevilla, Sara Garcia-Avila, Lourdes Florensa, Joan Gibert, Concepción Fernández-Rodríguez, Marta Salido, Anna Puiggros, Blanca Espinet, Luis Colomo, Beatriz Bellosillo, Ana Ferrer, Leonor Arenillas
Publikováno v:
Blood Advances. 6:3921-3931
Patients with oligomonocytic chronic myelomonocytic leukemia (OM-CMML) are currently classified according to the 2017 World Health Organization myelodysplastic syndromes classification. However, recent data support considering OM-CMML as a specific s
Autor:
Antonio Llombart-Cussac, Javier Cortés, Andrea Malfettone, Crina Popa, Miguel Sampayo-Cordero, Silvia Menéndez, Federico Rojo, Beatriz Bellosillo, Leonardo Mina, Ana Santaballa Bertran, Vanesa Quiroga, Alessandro Marco Minisini, Enrique Espinosa, Juan de la Haba, Lourdes Calvo, Begoña Bermejo, Meritxell Bellet, Joan Gibert, Laura Comerma, Manuel Ruíz-Borrego, Giuseppe Curigliano, Miguel Gil-Gil, José Manuel Pérez-García, Joan Albanell
Summary of all adverse events according to NCI-CTCAE version 4.0.3.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72568bda800ffb38bd5bdf1659e5cc64
https://doi.org/10.1158/1078-0432.22489440
https://doi.org/10.1158/1078-0432.22489440